The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2020
Filed:
May. 10, 2018
Applicant:
Shayne K. Morris, Ogden, UT (US);
Inventor:
Shayne K. Morris, Ogden, UT (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 45/00 (2006.01); A61K 39/02 (2006.01); A61K 49/00 (2006.01); A61K 35/747 (2015.01); A61K 35/745 (2015.01); A61K 35/744 (2015.01); A61K 9/00 (2006.01); A61K 35/741 (2015.01); A61K 35/76 (2015.01); A61K 47/44 (2017.01); A61K 47/18 (2017.01); A61K 47/22 (2006.01); A61K 47/08 (2006.01); A61K 47/10 (2017.01); A61K 47/42 (2017.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); C12N 7/00 (2006.01); A61K 35/742 (2015.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/747 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 35/741 (2013.01); A61K 35/742 (2013.01); A61K 35/744 (2013.01); A61K 35/745 (2013.01); A61K 35/76 (2013.01); A61K 47/08 (2013.01); A61K 47/10 (2013.01); A61K 47/18 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/42 (2013.01); A61K 47/44 (2013.01); C12N 7/00 (2013.01); A61K 2035/115 (2013.01); C12N 2795/10132 (2013.01); C12N 2795/10232 (2013.01); C12N 2795/10332 (2013.01);
Abstract
A system for treating and maintaining the health of the skin of a user. The system may include a topical formulation and an oral formulation. The topical formation may include various probiotic organisms selected for enhancing and treating the skin of a user. The oral formulation may include various probiotic organisms for enhancing and treating the skin of the user. The topical formulation and the oral formulation may be used cooperatively and simultaneously to produce a beneficial, synergistic effect.